Research is ongoing to develop better treatments and potential cures for sickle cell disease. Advances in gene editing technologies like CRISPR/Cas9 offer hope for correcting the mutation at the DNA level. Clinical trials are also underway to evaluate the efficacy and safety of these novel therapies.